Category Archives: News

FDA Approves Rituxan (rituximab) for Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) in Children

Print this page South San Francisco, CA — September 27, 2019 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Rituxan (rituximab), in combination with glucocorticoids, for the treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in… Read More »

Popular heartburn drug ranitidine recalled: What you need to know and do

If you or a family member take ranitidine (Zantac) to relieve heartburn, you may have heard that the FDA has found a probable human carcinogen (a substance that could cause cancer) in it. The story is unfolding quickly and many details remain murky. Here is what we know so far and what you should do.… Read More »

Medicaid may be the driver to reducing costs

Medicaid may be the best driver for healthcare cost reductions, according to Dr. Anita Cattrell, chief innovation officer for Evolent Health, which works with provider-led Medicaid plans to coordinate medical care with social resources for housing, food and behavioral health counseling. Cattrell co-developed Evolent’s Social Needs Index, which flags to physicians when aggregated data suggests… Read More »

Naturopathy is poised to ‘disrupt’ health-care status quo, proponents of controversial practice say

Its practitioners have a “philosophical aversion” to prescription drugs, embrace homeopathy — a practice experts dismiss as scientifically preposterous — and believe vitamin supplements can alter the course of incurable diseases. Now, proponents of naturopathy say the practice is poised to ultimately “disrupt” the status quo in health care. A new commentary argues naturopathy fulfills… Read More »